With official shortages ended, but the first generics gearing up for launch, companies are looking for the next generation of ...
Berenberg Bank analyst Kerry Holford maintained a Hold rating on Novartis (NVS – Research Report) yesterday and set a price target of $97.00.
Supported by world-class markets data from Dow Jones and FactSet, and partnering with Automated Insights, MarketWatch ...
Maxion Therapeutics Raises $72 million (£58 million) in an Oversubscribed Series A Financing to Advance its KnotBody® ...
Eli Lilly (LLY) believes its experimental weight-loss pill could make GLP-1 treatments more accessible worldwide.
"People come together, operators, with their supervisors at 6 a.m. every morning, and they talk about what issues they have and how they propose to solve it. Those get escalated through all levels of ...
K reports of America’s largest pharmaceutical companies show that they continue to avoid paying much, if any, U.S. corporate income tax.
The Italian Global Series Festival has launched with Evangeline Lilly and Adjoa Andoh winning awards and Bille August on the ...
Jeff Lilly has been named director of technology for Nexstar’s Chicago owned station WGN.
GE Aerospace is the latest company to announce an investment in the U.S. economy under the Trump administration. GE said the ...
Eli Lilly revealed major advancements in its alopecia and atopic dermatitis studies, likely driving its 3.77% stock rise. The ...
Eli Lilly’s rising fortunes tied to its weight loss and diabetes drugs led to a nine-figure payday for its top executive.
Some results have been hidden because they may be inaccessible to you
Show inaccessible results